ODDO BHF Initiates the Coverage of Aelis Farma With a “Buy” Recommendation
BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 – ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the « Company »), announces…
Details